Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-07-14 18:05 Tx date 2022-07-05 |
$CBDT
Empower Clinics Inc. (formerly Adira Energy Ltd.) |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
900,000 | |
Filed 2022-07-14 17:59 Tx date 2022-07-05 |
$CBDT
Empower Clinics Inc. (formerly Adira Energy Ltd.) |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+500,000 vol $0.08 each |
||
Filed 2022-07-14 17:59 Tx date 2022-07-05 |
$CBDT
Empower Clinics Inc. (formerly Adira Energy Ltd.) |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+500,000 vol $0.08 each |
900,000 | |
Filed 2021-12-23 22:04 Tx date 2021-12-22 |
$CBDT
Empower Clinics Inc. (formerly Adira Energy Ltd.) |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
Filed 2018-10-29 Tx date 2018-10-22 |
$BLIS
BlissCo Cannabis Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-29 Tx date 2018-10-22 |
$BLIS
BlissCo Cannabis Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-29 Tx date 2018-10-22 |
$BLIS
BlissCo Cannabis Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-29 Tx date 2018-10-24 |
$BLIS
BlissCo Cannabis Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$252,000
+800,000 vol $0.315 each |
800,000 | |
Filed 2017-10-16 Tx date 2017-10-10 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,016
-800 vol $2.52 each |
||
Filed 2017-10-16 Tx date 2017-10-10 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,016
-800 vol $2.52 each |
||
Filed 2017-10-16 Tx date 2017-10-10 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,081.64
-17,164 vol $2.51 each |
||
Filed 2017-10-16 Tx date 2017-10-10 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,120
-2,000 vol $2.56 each |
||
Filed 2017-10-16 Tx date 2017-10-10 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,081.64
-17,164 vol $2.51 each |
||
Filed 2017-10-16 Tx date 2017-10-10 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,120
-2,000 vol $2.56 each |
||
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,255
-500 vol $2.51 each |
24,239 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,857.50
-1,125 vol $2.54 each |
9,533 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,542
-600 vol $2.57 each |
8,933 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-185.00
-74 vol $2.50 each |
8,859 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,550
-5,000 vol $2.51 each |
3,859 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,764
-700 vol $2.52 each |
3,159 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,024
-800 vol $2.53 each |
2,359 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,968.27
-2,359 vol $2.53 each |
0 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,715
-9,886 vol $2.50 each |
24,739 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,136.25
-3,975 vol $2.55 each |
20,264 | |
Filed 2017-10-02 Tx date 2017-09-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-768.00
-300 vol $2.56 each |
19,964 | |
Filed 2017-08-28 Tx date 2017-08-25 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$33,938
+19,964 vol $1.70 each |
34,625 | |
Filed 2017-08-28 Tx date 2017-08-25 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-85,000
-50,000 vol $1.70 each |
273,460 | |
Filed 2017-03-31 Tx date 2017-03-28 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
57 - Exercise of rights
|
-3,238 vol |
3,238 | |
Filed 2017-03-31 Tx date 2017-03-28 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,693 vol |
14,661 | |
Filed 2017-03-27 Tx date 2017-03-22 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$501,250
+125,000 vol $4.01 each |
323,460 | |
Filed 2016-06-30 Tx date 2016-06-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
57 - Exercise of rights
|
-3,238 vol |
6,476 | |
Filed 2016-06-30 Tx date 2016-06-27 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,693 vol |
12,968 | |
Filed 2016-06-24 Tx date 2016-06-21 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$461,250
+75,000 vol $6.15 each |
198,460 | |
Filed 2015-06-04 Tx date 2015-06-02 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-8,640
-200 vol $43.20 each |
123,460 |